Fig. 1From: Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinomaResponse to PD-1 inhibition in patient with renal medullary carcinoma. a CT chest with contrast showing mediastinal lymphadenopathy prior to treatment with nivolumab (b) CT chest with contrast showing resolution of mediastinal lymphadenopathy after nine months on treatment with nivolumabBack to article page